These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4048488)

  • 21. [Prevalence of Trichomonas vaginalis Donné in women of Lódź population in 1955-1999 years].
    Kurnatowska A; Mamos AR
    Wiad Parazytol; 2001; 47 Suppl 1():9-12. PubMed ID: 16897945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [XI Clinical Day of Medical Parasitology].
    Kwaśniewska J
    Wiad Parazytol; 1973; 19(2):244-7. PubMed ID: 4736642
    [No Abstract]   [Full Text] [Related]  

  • 23. [Vaccination with Solco Trichovac. Immunological aspects of a new principle in the therapy and prevention of reinfection of trichomoniasis in women].
    Pavić R; Stojković L
    Gynakol Rundsch; 1982; 22 Suppl 2():27-38. PubMed ID: 6984685
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative microscopy, culture and serology studies on Trichomonas vaginalis].
    Beck KJ; Saathoff M; Merkl H
    Geburtshilfe Frauenheilkd; 1971 Jun; 31(6):551-60. PubMed ID: 5581794
    [No Abstract]   [Full Text] [Related]  

  • 25. Trimonil in a micronized form fro the treatment and the prevention of trichomonas vaginalis, Hemophilus vaginalis, candida (monilia) albicans and cervical ectropions.
    Karnaky KJ
    Southwest Med; 1972 Jan; 53(1):10-2. PubMed ID: 5060785
    [No Abstract]   [Full Text] [Related]  

  • 26. [Preliminary observations on the use of pimaricin in vaginitis due to Candida albicans, Trichomonas vaginalis and in aspecific vaginitis].
    De Luca Brunori I
    Minerva Ginecol; 1966 Aug; 18(15):840-6. PubMed ID: 5298569
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical and laboratory study of vaginitis. Evaluation of diagnostic methods and results of treatment.
    Burgess SG; Mancuso PG; Kalish PE; Rollender W
    N Y State J Med; 1970 Aug; 70(16):2086-91. PubMed ID: 5269916
    [No Abstract]   [Full Text] [Related]  

  • 28. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention.
    Van der Pol B
    Clin Infect Dis; 2007 Jan; 44(1):23-5. PubMed ID: 17143810
    [No Abstract]   [Full Text] [Related]  

  • 29. [Epidemiological studies on trichomoniasis in factories of the Wroclaw Province].
    Nowosad K; Kwoczyński MZ; Penar S
    Wiad Parazytol; 1973; 19(3):283-5. PubMed ID: 4732780
    [No Abstract]   [Full Text] [Related]  

  • 30. [Trichomoniasis in rural population].
    Wolyńska M; Soroczan W; Gulanowska H
    Wiad Parazytol; 1973; 19(3):301-3. PubMed ID: 4732784
    [No Abstract]   [Full Text] [Related]  

  • 31. [Routine examination of leukorrhea in 3347 patients with trichomonal vaginitis].
    Wang XY; Qiu FC; Zhou LJ; Chen J; Xiong YL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Oct; 22(5):319. PubMed ID: 15830896
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment and prevention of trichomoniasis of the urogenital organs].
    TEOKHAROV BA
    Sov Med; 1958 May; 22(5):100-3. PubMed ID: 13580560
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence of Trichomonas vaginalis infection in and around Surat.
    Chakraborty T; Mulla SA; Kosambiya JK; Desai VK
    Indian J Pathol Microbiol; 2005 Oct; 48(4):542-5. PubMed ID: 16366122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on etiologic agents of vaginitis].
    Shu M; Yu P; Yiao M
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):80-2. PubMed ID: 11938750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis.
    Brown HL; Fuller DD; Jasper LT; Davis TE; Wright JD
    Infect Dis Obstet Gynecol; 2004; 12(1):17-21. PubMed ID: 15460191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of intrauterine devices complicated by trichomonas vaginitis].
    Cisło M; Krzaklewski S; Resczyński A
    Wiad Parazytol; 1977; 23(5):595-8. PubMed ID: 607573
    [No Abstract]   [Full Text] [Related]  

  • 37. [Epidemiological characteristics of trichomoniasis in the textile industry].
    Kwoczyński MZ; Nowosad K; Petru T; Kwoczyńska K
    Wiad Parazytol; 1973; 19(3):309-11. PubMed ID: 4732786
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk factors for vaginal trichomoniasis among women in Basra, Iraq.
    Mahdi NK; Gany ZH; Sharief M
    East Mediterr Health J; 2001 Nov; 7(6):918-24. PubMed ID: 15332733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The incidence of vaginal candida and trichomonas infections and treatment of trichomonas vaginitis with clotrimazole.
    Schnell JD
    Postgrad Med J; 1974 Jul; 50 Suppl 1():79-81. PubMed ID: 4619466
    [No Abstract]   [Full Text] [Related]  

  • 40. Vaccination with SolcoTrichovac. Immunological aspects of a new approach for therapy and prophylaxis of trichomoniasis in women.
    Pavic R; Stojković L
    Gynakol Rundsch; 1983; 23 Suppl 2():27-38. PubMed ID: 6629132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.